# Erlanger account plan

> Erlanger Health is a Chattanooga safety-net health system with $1,359,057,864 FY2024 revenue, in talks to join Prisma Health.

## At a glance

Erlanger Health is a not-for-profit health system based in Chattanooga that serves Hamilton and Bledsoe counties and outlying areas in southeastern Tennessee, north Georgia and western North Carolina. Erlanger Medical Center runs the hospitals on the Baroness, East and North campuses, alongside two 25-bed rural hospitals, community health centers, home health and a Cyberknife service. As a safety-net provider it accepts patients regardless of their ability to pay; Medicare makes up about 37.0% of gross charges and TennCare/Medicaid about 19.0%. In the year ended June 30, 2024, total revenue, gains and support were $1,359,057,864, with operating income of $54,236,357. In July 2026 it signed a non-binding letter of intent to become part of Prisma Health; Jim Coleman is President and CEO.

## Business units

- **Erlanger Medical Center (EMC)**: The parent company and main hospitals on the Baroness, East and North campuses in Chattanooga, providing planning, finance, marketing and resource allocation for the affiliates. The original authority operated Baroness Erlanger Hospital and T.C. Thompson Children's Hospital.
- **Erlanger Bledsoe Hospital**: A 25-bed inpatient unit in Pikeville, Tennessee, bringing academic medical expertise to the Cumberland Plateau and Sequatchie Valley.
- **Erlanger Western Carolina Hospital**: A 25-bed hospital in Murphy, North Carolina (Murphy Medical Center), of which EMC became sole member on April 1, 2018.
- **Erlanger Community Health Centers**: Federally Qualified Health Centers, including Southside, Dodson Avenue, Premier Health and a school-based clinic, offering medical, behavioral health and dental care, partly funded by the Department of Health and Human Services.
- **ContinuCare HealthServices**: Home health and supportive services in Hamilton County and north Georgia, wholly owned by EMC.
- **Cyberknife of Chattanooga**: A 51%-owned company providing robotic stereotactic radiosurgery on EMC's campus, with all revenue from its contract with EMC.

## Strategic priorities

- **Partnership with Prisma Health**: In July 2026 Erlanger signed a non-binding letter of intent to become part of Prisma Health, which would include $2 billion in strategic capital investments over 15 years; the deal is in due diligence and needs board, county and regulatory approval.
- **Accelerate the five-year strategic plan**: Leadership expects the partnership's capital to let Erlanger expand access to care much sooner than it could alone.
- **Keep the safety-net mission**: Erlanger says it will keep treating uninsured patients and providing indigent care and community benefits if the partnership is approved.
- **Stronger credit and facilities**: Erlanger improved its bond rating from Baa3 to an A rating over four years, and its August 2024 Series 2024 bonds refinanced debt and funded facility improvements.

## Investments and deals

- **Prisma Health capital commitment**: If completed, the Prisma Health agreement would bring $2 billion in strategic capital investments over 15 years.
- **Series 2024 bond refinancing**: On August 14, 2024, Erlanger issued $319,410,000 Series 2024 bonds maturing through 2054 to refund earlier bonds and notes and pay for facility improvements.
- **Capital spending and IT**: Property and equipment purchases were $33,934,721 in FY2024, with about $13,600,000 left to complete construction in progress and $3,002,754 of software implementation fees capitalized.

## Challenges and risks

- **Reimbursement and regulatory change**: Leadership cites healthcare reimbursement challenges and the sunset of Tennessee's certificate of need law in 2030 as reasons to seek a partner.
- **Long-term capital needs**: Erlanger names its long-term capital needs as a driver of the Prisma Health partnership.
- **Qui tam litigation**: A False Claims Act suit alleges certain employed physicians were paid above fair market value from 2014 until 2021; Erlanger intends to defend it and recorded no reserve.
- **Supplemental funding at risk**: Erlanger may be ineligible to retain some Medicare DSH payments, with about $28,200,000 of reserves accrued, and TennCare supplemental payments are not guaranteed.
- **Uncompensated care**: Charity charges forgone totalled $174,658,047 in FY2024, and patient accounts receivable rose by $80,903,916 during the year.

## What leadership says

> "It gives us access to capital where we can accelerate our strategic plans in the market." — Jim Coleman, President and CEO, NewsChannel 9 report on the Prisma Health letter of intent, July 22, 2026

> "We really felt this was the right time to look for a partner instead of in a time when we're really desperate for a partner." — Jim Coleman, President and CEO, NewsChannel 9 report, July 22, 2026

> "Our mission doesn't change" — Jim Coleman, President and CEO, NewsChannel 9 report, July 22, 2026, on safety-net care after the partnership


## Where a supplier can help

- **Capital projects under the partnership**: The $2 billion of strategic capital investments over 15 years tied to the five-year plan would create demand for construction, equipment and technology suppliers.
- **Integration into a larger system**: Joining Prisma Health means systems and processes may be aligned, an opening for integration, IT and change management services once due diligence advances.
- **Revenue cycle and receivables**: Reimbursement pressure, rising patient receivables and high charity care point to revenue cycle, eligibility and patient financing offers.
- **Compliance support**: The qui tam suit over physician compensation and DSH eligibility questions point to compliance, physician compensation review and audit support.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Erlanger Health Consolidated Financial Statements and Other Information, Year Ended June 30, 2024 (audited, single audit)](https://app.fac.gov/dissemination/report/pdf/2024-06-GSAFAC-0000355154)

Annual report · 2025-03-20

- Erlanger Health is the Chattanooga, Tennessee academic health system serving Hamilton and Bledsoe counties and outlying areas in southeastern Tennessee, north Georgia and western North Carolina; effective July 1, 2023 it took over substantially all assets and operations of the Chattanooga-Hamilton County Hospital Authority and became a private 501(c)(3) not-for-profit.
- FY ended June 30, 2024: total revenue, gains and support of $1,359,057,864 (patient service revenue $1,264,966,711; other operating revenue $94,091,153) and operating income of $54,236,357.
- Excess of revenue and gains over expenses and losses was $71,028,910, helped by a $13,891,808 net gain from investments; net assets reached $507,263,371 against total assets of $1,087,244,448.
- Labour is the largest cost: salaries and wages of $594,410,129 plus employee benefits of $105,600,915, out of total operating expenses of $1,304,821,507; purchased services were $242,718,853, supplies $176,636,760 and drugs $101,530,713.
- Liquidity: cash and cash equivalents of $201,775,672 and investments of $267,564,388 at June 30, 2024; financial assets available for general expenditure within one year of $686,325,470.
- Payer exposure: Medicare accounted for about 37.0% of gross patient service charges, TennCare/Medicaid about 19.0% and Blue Cross Blue Shield about 15.0%.
- Debt: long-term debt of $238,215,662 at year end; on August 14, 2024 Erlanger issued $319,410,000 Series 2024 bonds to refund the Series 2014A bonds and notes and pay for facility improvements.
- Risks named: a qui tam False Claims Act / Stark Law suit unsealed in May 2024 over physician compensation from 2014 to 2021 (no reserve recorded), about $28,200,000 of DSH reserves still accrued, a frozen defined benefit pension plan with a $32,422,436 liability, and the geographic concentration in Southeast Tennessee.
- Charity care: charges forgone of $174,658,047, with estimated cost of $48,896,591; capital spending was $33,934,721 of property and equipment purchases.

### [Erlanger signs letter of intent to become part of South Carolina health system (NewsChannel 9, Jim Coleman)](https://newschannel9.com/news/local/erlanger-signs-letter-of-intent-to-partner-with-south-carolina-health-system-prisma-health-jim-coleman-hamilton-county-hospital-authority-nonprofit-strategic-partnership)

Executive talk · Jim Coleman, President and CEO · 2026-07-22

- Erlanger signed a non-binding letter of intent to become part of Prisma Health, a Greenville, South Carolina nonprofit system that operates 20 hospitals and serves more than 1.6 million patients annually.
- Coleman: "We will become part of a bigger system," adding that "It gives us access to capital where we can accelerate our strategic plans in the market"
- The agreement would include $2 billion in strategic capital investments over 15 years.
- Drivers of the decision after nearly a year of evaluation: reimbursement challenges, the sunset of Tennessee's certificate of need law in 2030 and long-term capital needs.
- Erlanger negotiated from strength: its bond rating improved from Baa3 to an A rating over four years; "We were in a position of strength," Coleman said.
- Erlanger has a five-year strategic plan that the investment would let it accelerate; Coleman would remain regional CEO of what would become Prisma Health East Tennessee.
- Safety-net role and indigent care continue: "Our mission doesn't change... We're still Erlanger."
- Next steps: due diligence, then approval by Erlanger's Board, the Erlanger Health Oversight Panel, the Hamilton County Commission and state and federal regulators.

## Questions about Erlanger

### What does Erlanger do?

Erlanger Health is a not-for-profit safety-net health system in Chattanooga, Tennessee, running hospitals on three campuses, two rural hospitals, community health centers and home health across southeastern Tennessee, north Georgia and western North Carolina.

### What is Erlanger's revenue?

Total revenue, gains and support were $1,359,057,864 in the year ended June 30, 2024, with operating income of $54,236,357.

### Who leads Erlanger?

Jim Coleman is President and CEO; he would remain regional CEO for East Tennessee if Erlanger joins Prisma Health.

### Is Erlanger merging with Prisma Health?

In July 2026 Erlanger signed a non-binding letter of intent to become part of Prisma Health, including $2 billion in strategic capital investments over 15 years; it is in due diligence and needs several approvals.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
